Baxter International is a US company operating worldwide in the pharmaceutical and medical technology sectors. The company produces drugs for anesthesiology and intensive care medicine, vaccines and medical devices.
According to Baxter's latest financial reports the company's current earnings are โน12.85 Billion. a decrease over its 2023 earnings that were of โน11.44 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2024 | -โน51.03 Billion | -545.86% |
2023 | โน11.44 B | -105.3% |
2022 | -โน215.82 Billion | -269.8% |
2021 | โน127.09 B | 14.32% |
2020 | โน111.17 B | 33.2% |
2019 | โน83.46 B | -41.53% |
2018 | โน142.75 B | 36.32% |
2017 | โน104.72 B | -75.43% |
2016 | โน426.29 B | 1057.48% |
2015 | โน36.82 B | -79.17% |
2014 | โน176.83 B | -18.81% |
2013 | โน217.79 B | -12.39% |
2012 | โน248.59 B | 2.85% |
2011 | โน241.71 B | 48.62% |
2010 | โน162.63 B | -30.87% |
2009 | โน235.26 B | 11.05% |
2008 | โน211.85 B | 16.46% |
2007 | โน181.90 B | 21.08% |
2006 | โน150.24 B | 20.91% |
2005 | โน124.25 B | 233.49% |
2004 | โน37.25 B | -62.22% |
2003 | โน98.61 B | -18.08% |
2002 | โน120.38 B | 45.12% |
2001 | โน82.95 B | 1.9% |
2000 | โน81.40 B | -9.99% |
1999 | โน90.43 B | 99.43% |
1998 | โน45.34 B | 0.76% |
1997 | โน45.00 B | -34.05% |
1996 | โน68.23 B | 51.34% |
1995 | โน45.09 B | -34.58% |
1994 | โน68.92 B | -342.73% |
1993 | -โน28.4 Billion | -142.36% |
1992 | โน67.03 B | -3.23% |
1991 | โน69.27 B | 666.67% |
1990 | โน9.03 B | -83.52% |
1989 | โน54.81 B | -14.5% |
1988 | โน64.10 B | 7.66% |
1987 | โน59.54 B | 26.74% |
1986 | โน46.98 B | 115.3% |
1985 | โน21.82 B | 10.84% |
1984 | โน19.68 B |